Protalix Biotherapeutics (PLX)
:PLX
Total Valuation
Protalix has a market cap or net worth of $174.03M. The enterprise value is $163.65M.
Market Cap$174.03M
Enterprise Value$163.65M
Share Statistics
Protalix has 80,571,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,571,640
Owned by Insiders3.88%
Owned by Institutions4.20%
Financial Efficiency
Protalix’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -9.61%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-9.61%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee247.62K
Profits Per Employee-31.00K
Employee Count213
Asset Turnover0.64
Inventory Turnover1.05
Valuation Ratios
The current PE Ratio of Protalix is ―. Protalix’s PEG ratio is 0.07.
PE Ratio―
PS Ratio2.68
PB Ratio2.93
Price to Fair Value2.93
Price to FCF-10.37
Price to Operating Cash Flow-14.15
PEG Ratio0.07
Income Statement
In the last 12 months, Protalix had revenue of 52.74M and earned -6.60M in profits. Earnings per share was -0.08.
Revenue52.74M
Gross Profit25.75M
Operating Income-5.50M
Pretax Income-5.61M
Net Income-6.60M
EBITDA-4.04M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -11.99M and capital expenditures 0.00, giving a free cash flow of -11.99M billion.
Operating Cash Flow-11.99M
Free Cash Flow-11.99M
Free Cash Flow per Share-0.15
Dividends & Yields
Protalix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change-16.28%
50-Day Moving Average2.59
200-Day Moving Average2.00
Relative Strength Index (RSI)34.55
Average Volume (3m)1.31M
Important Dates
Protalix upcoming earnings date is May 8, 2026, TBA (Confirmed).
Last Earnings DateMar 18, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Protalix as a current ratio of 2.51, with Debt / Equity ratio of 17.25%
Current Ratio2.51
Quick Ratio1.54
Debt to Market Cap<0.01
Net Debt to EBITDA1.58
Interest Coverage Ratio-4.62
Taxes
In the past 12 months, Protalix has paid 996.00K in taxes.
Income Tax996.00K
Effective Tax Rate-0.18
Enterprise Valuation
Protalix EV to EBITDA ratio is -33.46, with an EV/FCF ratio of -9.91.
EV to Sales2.56
EV to EBITDA-33.46
EV to Free Cash Flow-9.91
EV to Operating Cash Flow-11.26
Balance Sheet
Protalix has $14.68M in cash and marketable securities with $8.32M in debt, giving a net cash position of $6.36M billion.
Cash & Marketable Securities$14.68M
Total Debt$8.32M
Net Cash$6.36M
Net Cash Per Share$0.08
Tangible Book Value Per Share$0.61
Margins
Gross margin is 48.82%, with operating margin of -10.43%, and net profit margin of -12.52%.
Gross Margin48.82%
Operating Margin-10.43%
Pretax Margin-10.63%
Net Profit Margin-12.52%
EBITDA Margin-7.65%
EBIT Margin-10.43%
Analyst Forecast
The average price target for Protalix is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside455.56% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast35.42%
EPS Growth Forecast―